Your email has been successfully added to our mailing list.

×
-0.00148367952522252 -0.00741839762611273 0 -0.0188130563798219 0.00299703264094955 0.00590504451038583 0.0163204747774481 0.00741839762611286
Stock impact report

ObsEva down 42% on late-stage linzagolix data [Seeking Alpha]

ObsEva SA - Common Shares (OBSV) 
Last obseva sa - common shares earnings: 3/5 01:00 am Check Earnings Report
Company Research Source: Seeking Alpha
ObsEva SA (OBSV-41.8%resultsBoth studies, PRIMROSE 1 & 2, met the primary endpoint demonstrating a statistically significant proportion of responders in both the 200 mg and 100 mg arms as defined by menstrual blood loss volume reduction at week 24.Investors may be reacting to the safety profile. The proportions of treated patients experiencing at least one treatment-emergent adverse event ranged from 50.5% to 66.0%, although not that much different from the range of 44.8% - 53.8% in the control arms.Compared to AbbVie's (ABBV+0.3%On the bone loss front, linzagolix was associated with reductions in lumbar spine bone density of -0.8% to -2.4% at week 24 compared to -0.9% to -3.1% for elagolix.Related ticker: Myovant Sciences (MYOV+0.6% Show less Read more
Impact Snapshot
Event Time:
OBSV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for OBSV alerts
Opt-in for
OBSV alerts

from News Quantified
Opt-in for
OBSV alerts

from News Quantified